Expression of Tissue Inhibitors of Metalloproteinases (TIMPs) in Hepatocellular Carcinoma

Overview

Journal Korean J Intern Med

Specialty General Medicine

Date 2001 Mar 13

PMID 11242804

Citations 3

Authors

Y E Joo

Y H Seo

W S Lee

H S Kim

S K Choi

J S Rew

C S Park

S J Kim

Affiliations

Soon will be listed here.

Abstract

Background: Matrix metalloproteinases (MMPs) have been implicated in the remodelling of extracellular matrix (ECM), including basement membrane. ECM remodelling is associated with pathological processes, including hepatic fibrosis, tumor invasion and metastasis. Tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 were known to inhibit MMP-9 and MMP-2, respectively. In the present study, we examined the expression of TIMP-1 and TIMP-2 in surgical specimen pairs of hepatocellular carcinoma and nontumoral liver and the correlation between their expression and clinicopathological characteristics.

Methods: The localization of both transcripts and protein of TIMP-1 and TIMP-2 was studied by using in situ hybridization and immunohistochemistry.

Results: TIMP-1 and TIMP-2 mRNA transcripts were found in tumor cells, hepatocyte, sinusoidal cells, endothelial cells and stromal cells. Signal intensity of TIMP-1 was stronger than that of TIMP-2. The results of immunohistochemical stainings were concordant with those obtained by in situ hybridization. Expression of TIMP-1 and TIMP-2 was observed in tumorous tissue, in nontumorous tissue and in the portions of the tumors adjacent to the capsules. However, a clear difference in TIMP-1 and TIMP-2 mRNA expression was not observed among the three tissue types. The intensity of TIMP-2 expression was generally weaker than that of TIMP-1, and the intensity of TIMP-1 and TIMP-2 mRNA expression did not correlate with variable clinicopathological characteristics.

Conclusion: TIMPs was expressed in tumor cells and many cell types of the nontumoral liver. Further investigations for TIMPs' unknown functional role are needed.

Citing Articles

Liver Disease: Induction, Progression, Immunological Mechanisms, and Therapeutic Interventions.

Neshat S, Quiroz V, Wang Y, Tamayo S, Doloff J Int J Mol Sci. 2021; 22(13).

PMID: 34202537 PMC: 8267746. DOI: 10.3390/ijms22136777.

Radix Tetrastigma hemsleyani flavone inhibits proliferation, migration, and invasion of human lung carcinoma A549 cells.

Zhong L, Zheng J, Sun Q, Wei K, Hu Y Onco Targets Ther. 2016; 9:635-41.

PMID: 26893573 PMC: 4745953. DOI: 10.2147/OTT.S92707.

Usefulness of MMP-9/TIMP-1 in predicting tumor recurrence in patients undergoing curative surgical resection for gastric carcinoma.

Seo Y, Park J, Kim J, Kim J, Yeon J, Kim J Dig Dis Sci. 2007; 52(3):753-9.

PMID: 17237995 DOI: 10.1007/s10620-006-9535-0.

References

BISSELL D, Friedman S, Maher J, Roll F . Connective tissue biology and hepatic fibrosis: report of a conference. Hepatology. 1990; 11(3):488-98. DOI: 10.1002/hep.1840110322. View

DErrico A, Garbisa S, Liotta L, Castronovo V, Stetler-Stevenson W, Grigioni W . Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Mod Pathol. 1991; 4(2):239-46. View

Gressner A, Bachem M . Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis. Semin Liver Dis. 1990; 10(1):30-46. DOI: 10.1055/s-2008-1040455. View

Ries C, Petrides P . Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe Seyler. 1995; 376(6):345-55. View

Murawaki Y, Yamada S, Koda M, Hirayama C . Collagenase and collagenolytic cathepsin in normal and fibrotic rat liver. J Biochem. 1990; 108(2):241-4. DOI: 10.1093/oxfordjournals.jbchem.a123187. View

Arii S, Mise M, Harada T, Furutani M, Ishigami S, Niwano M . Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential. Hepatology. 1996; 24(2):316-22. DOI: 10.1053/jhep.1996.v24.pm0008690399. View

Friedman S . Closing in on the signals of hepatic fibrosis. Gastroenterology. 1997; 112(4):1406-9. DOI: 10.1016/s0016-5085(97)70158-6. View

Yamamoto H, Itoh F, Adachi Y, Sakamoto H, Adachi M, Hinoda Y . Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma. Gastroenterology. 1997; 112(4):1290-6. DOI: 10.1016/s0016-5085(97)70143-4. View

Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T . Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res. 1993; 53(22):5365-9. View

10.

Lefebvre V, Peeters-Joris C, Vaes G . Modulation by interleukin 1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochim Biophys Acta. 1990; 1052(3):366-78. DOI: 10.1016/0167-4889(90)90145-4. View

11.

Reed J, Manahan L, Park C, Brigati D . Complete one-hour immunocytochemistry based on capillary action. Biotechniques. 1992; 13(3):434-43. View

12.

Cawston T . Proteinases and inhibitors. Br Med Bull. 1995; 51(2):385-401. DOI: 10.1093/oxfordjournals.bmb.a072968. View

13.

Emonard H, Grimaud J . Matrix metalloproteinases. A review. Cell Mol Biol. 1990; 36(2):131-53. View

14.

Rojkind M, Martinez-Palomo A . Increase in type I and type III collagens in human alcoholic liver cirrhosis. Proc Natl Acad Sci U S A. 1976; 73(2):539-43. PMC: 335945. DOI: 10.1073/pnas.73.2.539. View

15.

McCune B, Mullin B, Flanders K, JAFFURS W, Mullen L, Sporn M . Localization of transforming growth factor-beta isotypes in lesions of the human breast. Hum Pathol. 1992; 23(1):13-20. DOI: 10.1016/0046-8177(92)90004-m. View

16.

Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A . Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci. 1994; 107 ( Pt 9):2373-9. DOI: 10.1242/jcs.107.9.2373. View

17.

Friedman S . Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med. 1993; 328(25):1828-35. DOI: 10.1056/NEJM199306243282508. View

18.

Khokha R . Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst. 1994; 86(4):299-304. DOI: 10.1093/jnci/86.4.299. View

19.

Khokha R, Denhardt D . Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion. Invasion Metastasis. 1989; 9(6):391-405. View

20.

Visscher D, Hoyhtya M, Ottosen S, Liang C, Sarkar F, Crissman J . Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer. 1994; 59(3):339-44. DOI: 10.1002/ijc.2910590308. View